“Virostatics” as a Potential New Class of HIV Drugs

E-ISSN： 1873-4286|10|32|4103-4120

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.10, Iss.32, 2004-12, pp. : 4103-4120

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Virostatics: A New Class of Anti-HIV Drugs

Current Medicinal Chemistry, Vol. 14, Iss. 2, 2007-01 ,pp. : 233-241

Bentham Science Publishers

Access to resources Recommend Favorite

Small-Molecule Antagonists of CCR5 and CXCR4: A Promising New Class of Anti-HIV-1 Drugs

Current Pharmaceutical Design, Vol. 10, Iss. 17, 2004-07 ,pp. : 2041-2062

Bentham Science Publishers

Access to resources Recommend Favorite

Vasopeptidase Inhibitors: A New Class of Drugs

Heart Drug, Vol. 1, Iss. 2, 2004-11 ,pp. : 96-102

Karger

Access to resources Recommend Favorite

New Platinum and Ruthenium Complexes - the Latest Class of Potential Chemotherapeutic Drugs - a Review of Recent Developments in the Field

Mini Reviews in Medicinal Chemistry, Vol. 9, Iss. 13, 2009-11 ,pp. : 1489-1503

Bentham Science Publishers

Access to resources Recommend Favorite

The discovery of a class of novel HIV-1 maturation inhibitors and their potential in the therapy of HIV

By Yu Donglei Wild Carl T Martin David E Morris-Natschke Susan L Chen Chin-Ho Allaway Graham P Lee Kuo-Hsiung

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 6, 2005-06 ,pp. : 681-693

Informa Healthcare

Access to resources Recommend Favorite